Patents by Inventor Hector BeltrandelRio

Hector BeltrandelRio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human kinases and polynucleotides encoding the same, and uses thereof
    Patent number: 7374932
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: May 20, 2008
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: D. Wade Walke, Erin Hilbun, Gregory Donoho, C. Alexander Turner, Jr., Gwenn Hansen, Hector BeltrandelRio, Isaac Van Sligtenhorst
  • Novel human kinases and polynucleotides encoding the same, and uses thereof
    Publication number: 20070270506
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: December 29, 2004
    Publication date: November 22, 2007
    Inventors: D. Walke, Erin Hilbun, Gregory Donoho, C. Turner, Gwenn Hansen, Hector BeltrandelRio, Isaac Sligtenhorst
  • Human kinases and polynucleotides encoding the same, and uses thereof
    Patent number: 6858419
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: February 22, 2005
    Assignee: Lexicon Genetics Incorporated
    Inventors: D. Wade Walke, Erin Hilbun, Gregory Donoho, C. Alexander Turner, Jr., Gwenn Hansen, Hector BeltrandelRio, Isaac Van Sligtenhorst
  • Compounds for treating disorders where a decreased level of plasma FFA is desired
    Publication number: 20020082254
    Abstract: The present invention relates to novel compounds, compositions containing them, and their use for treating medical disorders where a decreased level of plasma free fatty acids (FFA) is desired.
    Type: Application
    Filed: August 17, 2001
    Publication date: June 27, 2002
    Inventors: Hector Beltrandelrio, Poul Jacobsen, Johannes Cornelis De Jong